Nodakenin

CAS No. 495-31-8

Nodakenin( —— )

Catalog No. M18650 CAS No. 495-31-8

Nodakenin is a compound with anti-allergic and anti-inflammatory activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
2MG 29 In Stock
5MG 48 In Stock
10MG 67 In Stock
25MG 107 In Stock
50MG 152 In Stock
100MG 222 In Stock
200MG 331 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nodakenin
  • Note
    Research use only, not for human use.
  • Brief Description
    Nodakenin is a compound with anti-allergic and anti-inflammatory activities.
  • Description
    Nodakenin is a compound with anti-allergic and anti-inflammatory activities.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Male ICR mice.Dosage:2.5, 5, 10 and 20 mg/kg.Administration:p.o, single dose.Result:Reversed in step-through latency induced by scopolamine.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    AChE
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    495-31-8
  • Formula Weight
    408.4
  • Molecular Formula
    C20H24O9
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (244.86 mM)
  • SMILES
    c1(=O)ccc2cc3c(cc2o1)O[C@H](C3)C(C)(C)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Park SJ,et al. Effect of nodakenin on atopic dermatitis-like skin lesions. Biosci Biotechnol Biochem. 2014;78(9):1568-71.
molnova catalog
related products
  • Gastrin-Releasing Pe...

    Gastrin-releasing peptide is a regulatory human peptide that elicits gastrin release and regulates gastric acid secretion and enteric motor function.

  • Aristolone

    Aristolone has potential anti-cancer activity.

  • 3-Morpholino-1-(4-(2...

    3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one shows antitumor activity in a human colon cancer cell line and may be used to combat thrombosis.